Benzodiazepine Withdrawal Phenomena
The DOI matches its Crossref record.
Abstract
A withdrawal syndrome is described in 10 patients who claimed to be unable to discontinue benzodiazepines. A high dose group took the equivalent of a mean of 135 mg diazepam/day, and the normal dose group of 20 mg/day. Associated with the gradual reduction of medication was the emergence of severe symptoms of anxiety as well as sensory intolerance, perceptual disturbances and weight loss. The withdrawal syndrome subsided after 2 weeks and was similar in both groups of patients. EEG changes were detected on withdrawal opposite to those known to be associated with initiation of diazepam treatment. The measures tended to revert to the baseline after a drug-free period. One reason why chronic users of diazepam experience difficulty in stopping medication may be the development of a withdrawal syndrome even after moderate dosage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, symptoms that persisted for months or even years after complete benzodiazepine discontinuation were observed decades ago [5, 6].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [5]
Citations
Cites
Still being checked.
Cited by
Items 101–138 of 138
Night sedation in the admission wards of a psychiatric hospital
Fry, R. P. W. (1989) · Psychiatric Bulletin · doi:10.1192/pb.13.4.184 · Cited by 5
Major Depression and Sedative-Hypnotic Use Disorder: a Review
Chen, L., Kaufmann, C. N., & Mojtabai, R. (2018) · Current Addiction Reports · doi:10.1007/s40429-018-0218-7 · Cited by 4
Brenner, P. M., Wolf, B., Grohmann, R., & Rüther, E. (1988) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(88)90025-7 · Cited by 4
Long-Term Treatment of Anxiety: Benefits and Drawbacks
LADER, M. H. (1988) · Springer eBooks · doi:10.1007/978-3-642-73280-5_16 · Cited by 5
Self-citationManagement of mixed affective symptoms in primary care: a critical experiment
Ancill, R. J., Poyser, J., Davey, A., & Kennerson, A. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb01235.x · Cited by 4
Parr, J. M., Kavanagh, D. J., Young, R. M., Stubbs, B., & Bradizza, N. (2013) · Behaviour Change · doi:10.1017/bec.2013.7 · Cited by 3
“Email: david.kavanagh@qut.edu.au 74 Behaviour Change Volume 30 Number 2 2013 pp. 74–83 c©The Authors 2013 doi 10.1017/bec.2013.7 doses (Hallstrom & Lader, 1981; Lader, 1983; MacKinnon & Parker, 1982).”
InfluentialA new scale for the evaluation of benzodiazepine withdrawal symptoms: Sessb
Cassano, G., Petracca, A., & Cesana, B. M. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80171-7 · Cited by 3
Bond, A. J., & LADER, M. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_17 · Cited by 3
Self-citationClobazam in the treatment of anxiety
Beaumont, G. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100704 · Cited by 3
Treatment of sedative-hypnotic dependence
Dar, K., & Kumar, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.023 · Cited by 3
Delusional Depression following Benzodiazepine Withdrawal
Keshavan, M. S., Moodley, P., Eales, M. J., Joyce, E. M., & Yeragani, V. K. (1988) · The Canadian Journal of Psychiatry · doi:10.1177/070674378803300709 · Cited by 3
Benzodiazepin-Abusus Epidemiologische und klinisch-klassifikatorische Aspekte
Laux, G., & König, W. (1986) · Springer eBooks · doi:10.1007/978-3-642-70952-4_28 · Cited by 3
Comments on Matticket al.: the need for independent data re‐analyses
Caplehorn, J. R. M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00547.x · Cited by 3
Severity of Withdrawal in Subjects Exposed to a Combination of Alcohol and Minor Tranquillisers
Thomas, C. S., Spurrell, M., Hackett, R. D., & Hore, B. D. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.1.83 · Cited by 3
The EEG in hypnosedative drug withdrawal and dependence
van Sweden, B. (1984) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00381359 · Cited by 3
Benzodiacepinas en toxicómanos: ¿Problema o solución?
Lligoña, A. (2000) · Adicciones · doi:10.20882/adicciones.655 · Cited by 3
Approaches to managing benzodiazepines
Gold, J. A. (2020) · Pharmacy Today · doi:10.1016/j.ptdy.2020.02.020 · Cited by 2
Pharmacology of Sedatives, Hypnotics, and Anxiolytics
Sloan, J. W., & Wala, E. P. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_27 · Cited by 2
Wala, E. P., Sloan, J. W., & Jing, X. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00125-2 · Cited by 2
Behavioural approaches to anxiety disorders
Drummond, L. M. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.809.222 · Cited by 2
Medikamentenmißbrauch und -abhängigkeit bei stationären psychiatrischen Patienten
Wolf, B., Poser, W., Schmidt, L. G., & Rüther, E. (1987) · Suchtproblematik · doi:10.1007/978-3-642-82958-1_31 · Cited by 2
Voshaar, R. C. O. (2003) · Radboud Repository (Radboud University) · Cited by 2
Ramírez, O. I., & Pérez, M. F. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788452667 · Cited by 1
Welch, S., & Farrell, M. (2012) · doi:10.1093/med/9780199696758.003.0065 · Cited by 1
Nobre, M., & Kurihara, A. C. Z. S. (2023) · African journal of rhetoric · doi:10.21134/haaj.v23i1.721 · Cited by 1
Ashton, H. (1997) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00252-1 · Cited by 1
Saxon, L. (2007) · Figshare · Cited by 1
Benzodiazepine Use and Addiction among Alcoholics
Miller, N. S., & Gold, M. S. (1991) · Springer eBooks · doi:10.1007/978-1-4899-3550-2_13
Analgosedierung opiat-, barbiturat- und benzodiazepinabhängiger Patienten
Jage, J. (1988) · Springer eBooks · doi:10.1007/978-3-642-73678-0_9
Attempted therapy of benzodiazepine withdrawal symptoms with carbamazepine
Munjiza, M. G. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90224-a
de la Villarmois, E. A., Gabach, L. A., & Pérez, M. F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17103-6_13
Strian, F. (1983) · Springer eBooks · doi:10.1007/978-3-642-93245-8_9
Neukirchen, F. S. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7696
(1986) · Elsevier eBooks · doi:10.1016/b978-0-12-160230-7.50026-5
Büchl, R. (2013) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Pain, T. (1994) · TSpace (University of Toronto)
睡眠障害に伴う社会生活場面の認知に関する臨床心理学的研究 : 薬物療法を受ける睡眠障害患者の心理社会的援助に向けて
Yu, C. (2017) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00075498
Metadata
- Authors
- Hallstrom, C., & Lader, M.
- Venue
- International Pharmacopsychiatry
- Publisher
- S. Karger AG
- Published
- 2017-08-11
- Volume
- 16
- Issue
- 4
- Pages
- 235-244
- ISSN
- 0020-8272 (ISSN-L)
- 2504-2580
- OpenAlex
- W2418562842
- Cited by
- 132
- References
- 0
- Citations by year
- 2023: 2 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- International Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine withdrawal syndrome, diazepam, withdrawal symptoms, anxiety, perceptual disorders, weight loss, EEG changes, dose dependence, drug discontinuation
- MeSH terms
- Adult, Anxiety, Benzodiazepines, Body Weight, Electroencephalography, Evoked Potentials, Auditory, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Time Factors, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.